A Global Survey of Potential Acceptance of a COVID-19 Vaccine
By: Jeffrey V. Lazarus, Scott C. Ratzan, Adam Palayew, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, Spencer Kimball & Ayman El-Mohandes
Source: Nature
Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 48.1% reported that they would accept their employer’s recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer’s advice to do so.
VARN2023 Conference Report (French)
Quand les communautés dirigent, l’immunisation mondiale réussit
VARN2023 Conference Report
Findings and insights from the Sabin Vaccine Institute’s VARN2023 conference
VARN2022: Shaping Global Vaccine Acceptance with Localized [Peer-Reviewed] Knowledge
Some of the most relevant findings are now available through the VARN2022 Supplement via BMC Proceedings...
Community-led Strategies to Aid Vaccine Acceptance: Nine Case Studies from Around the World
These case-study reports inform action and investment around the globe that seek to build more vaccine confident communities.
